NCT01028183View on ClinicalTrials.gov

Impact of Maternal-infant Therapeutics on Safety, Mortality, and Disability

WithdrawnOBSERVATIONAL

0

Timeline

Start Date

August 31, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2013

Conditions

Gastroesophageal RefluxPresumed SepsisPatent Ductus ArteriosusChronic Lung DiseaseNeurodevelopmental Impairment

Trial Locations (1)

27715

Duke Clinical Research Institute, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER